Suchergebnisse - "Zou, Yutong"

PubPharm (126)

31

Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes

enthalten in: Frontiers in endocrinology | 2023

von Zhao, L. | Zou, Y. | Wu, Y. | +9

32

Corrigendum : Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer's disease: a bibliometric analysis

enthalten in: Frontiers in aging neuroscience | 2023

von Zou, Y. | Li, L. | Guan, L. | +6

ErratumFor: Front Aging Neurosci. 2023 Sep 27;15:1196272. - PMID 37829140

33

Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals : NHANES 1999-2008

enthalten in: Frontiers in cardiovascular medicine | 2023

von Guan, L. | Li, L. | Zou, Y. | +2

34

Expanding flavone and flavonol production capabilities in Escherichia coli

enthalten in: Frontiers in bioengineering and biotechnology | 2023

von Yiakoumetti, A. | Hanko, E. | Zou, Y. | +9

35

A robust LC-MS/MS method to measure 8-oxoGuo, 8-oxodG, and NMN in human serum and urine

enthalten in: Analytical biochemistry | 2023

von Zou, Y. | Ma, X. | Tang, Y. | +8

36

Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria : A Biopsy-Based Study

enthalten in: Journal of clinical medicine | 2022

von Wang, T. | Zhang, J. | Wang, Y. | +10

37

Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes

enthalten in: Renal failure | 2022

von Zhao, L. | Han, Q. | Zhou, L. | +14

38

Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease

enthalten in: Renal failure | 2022

von Zou, Y. | Zhao, L. | Zhang, J. | +14

39

Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2022

von Tang, Y. | Zou, Y. | Cui, J. | +4

40

Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study

enthalten in: Acta diabetologica | 2022

von Zou, Y. | Zhao, L. | Zhang, J. | +9